Filing Flows › Enovix (ENVX) › Q1 2026 › vs Q4 2025
Enovix (ENVX) Q1 2026 vs Q4 2025 (quarter over quarter)
Enovix's revenue fell $3.7M (-33%) from $11.3M in Q4 2025 to $7.6M in Q1 2026.
Enovix, Q1 2026: revenue $7.6M (+49% year over year), operating margin -577.6%, net loss $38.3M, operating cash flow −$33.1M. The chart draws each line against Q4 2025, the increases inside each band.
Every line
| Line | Q1 2026 | Q4 2025 | Change | % |
|---|---|---|---|---|
| Revenue | $7.6M | $11.3M | −$3.7M | -33% |
| Other income, net | $5.5M | $9.1M | −$3.6M | -39% |
| Income tax benefit | $129K | −$133K | $262K | — |
| Net loss | $38.3M | $35.0M | $3.2M | +9% |
| Costs & expenses | $51.5M | $55.4M | −$3.9M | -7% |
| Operating costs | $51.5M | $55.3M | −$3.8M | -7% |
| Cost of revenue | $6.0M | $8.8M | −$2.7M | -31% |
| Research & development | $26.5M | $28.1M | −$1.5M | -6% |
| SG&A | $18.9M | $18.4M | $504K | +3% |
| Operating cash sources | $54.2M | $46.8M | $7.4M | +16% |
| Depreciation & amortization | $9.4M | $8.4M | $933K | +11% |
| Share-based compensation | $11.8M | $11.4M | $371K | +3% |
| Cash used in operations | $33.1M | $27.0M | $6.1M | +22% |
| Net loss absorbed | $38.3M | $35.0M | $3.2M | +9% |
| Working capital & other | $15.9M | $11.8M | $4.2M | +35% |
Questions
How much did Enovix's revenue grow quarter over quarter in Q1 2026?
Enovix's revenue fell $3.7M (-33%) from $11.3M in Q4 2025 to $7.6M in Q1 2026.